FIELD: medicine; veterinary medicine.
SUBSTANCE: invention relates to the use of 2-methyl-N-(2-methylphenyl)-4-(2-furyl)-5-cyano-6-({2-[(4-ethoxyphenyl)amino]-2-oxoethyl}thio)-1,4-dihydropyridine-3-carboxamide of formula (I) as a hypoglycemic, hypolipidemic and weight loss agent.
EFFECT: invention provides hypoglycemic, hypolipidemic effects, promotes weight loss and can be used in medicine and veterinary medicine.
1 cl, 2 tbl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
2-METHYL-N-(2-METHYLPHENYL)-4-(2-FURYL)-5-CYANO-6-({2-[(4-ETHOXYPHENYL)AMINO]-2-OXOETHYL}THIO)-1,4-DIHYDROPYRIDINE-3-CARBOXAMIDE EXHIBITING ANALGESIC PROPERTIES | 2023 |
|
RU2813896C1 |
4-(2-METHYL-6-{[2-(DIPHENYLAMINO)-2-OXOETHYL]THIO}-4-FUR-2-YL-5-CYANO-1,4-DIHYDROPYRIDINE-3-CARBOXAMIDO)BENZOIC ACID ETHYL ETHER SHOWING ANTI-INFLAMMATORY PROPERTIES | 2022 |
|
RU2792595C1 |
APPLICATION OF BENZYL 6-({2-[(3,4-DIMETHYLPHENYL)AMINO]-2-OXOETHYL}THIO)-2-METHYL-4-(4-CHLOROPHENYL)-5-CYANO-1,4-DIHYDROPYRIDINE-3-CARBOXYLATE AS HEPATOPROTECTIVE AGENT | 2021 |
|
RU2755349C1 |
USE OF RHODANINE DERIVATIVE 3-(2-PHENYLETHYL)-2-THIOXO-1,3 THIAZOLIDIN-4-ONE FOR CORRECTION OF METABOLIC DISORDERS | 2019 |
|
RU2768171C2 |
THERAPEUTIC AGENT CONTAINING COMBINED USE OF COMBINATION OF DPP-IV INHIBITOR AND OTHER THERAPEUTIC AGENT FOR TREATING DIABETES | 2009 |
|
RU2523552C2 |
(2S)-3-(4-{2-[4-(2-{[(1R,4AR,7S)-7-ETHYNYL-1,4A,7-TRIMETHYL-1,2,3,4,4A,4B,5,6,7,8,10,10A-DODECAHYDROPHENANTHREN-1-YL]FORMAMIDO}ETHOXY)PHENYL]ETHOXY}PHENYL)-2-ETHOXY-PROPANOIC ACID FOR THERAPY AND PREVENTION OF METABOLIC SYNDROME | 2023 |
|
RU2813464C1 |
BIS[3-(4-CHLOROPHENYL)-1-(4-METHYLPHENYL)CARBOXAMIDO-1,3-PROPANEDIONATO]OXOVANADIUM, HAVING HYPOGLYCEMIC AND ANTIHYPOXIC ACTIVITY | 2010 |
|
RU2432355C2 |
COMPOSITION FOR METABOLIC SYNDROME CORRECTION | 2016 |
|
RU2616241C1 |
PHARMACEUTICAL COMPOSITIONS | 2010 |
|
RU2532330C2 |
METHOD FOR SIMULATING INHIBITION STATE OF FUNCTIONAL ACTIVITY OF GLYCOPROTEIN-P WITH DIPEPTIDYL PEPTIDASE 4 INHIBITOR | 2015 |
|
RU2602688C1 |
Authors
Dates
2024-01-30—Published
2023-07-17—Filed